Cognitive Impairment in Atrial Fibrillation
NCT01816308 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 888
Last updated 2019-09-09
Summary
This study aims to compare the incidence of new-onset cognitive impairments and change in existing impairment status between AF patients undergoing either catheter ablation or remaining on anti-arrhythmic drugs (AAD) as assessed by Montreal Cognitive Assessment (MoCA).
Conditions
Sponsors & Collaborators
-
Texas Cardiac Arrhythmia Research Foundation
lead OTHER
Principal Investigators
-
Andrea Natale, MD · TCAI
-
Mitra Mohanty, MD · TCAI
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2020-06-30
- Completion
- 2022-12-31
Countries
- United States
Study Locations
More Related Trials
-
Symptom Preoccupation in Atrial Fibrillation (AF) and Its Role in AF-related Disability
NCT04123327 ·Status: COMPLETED
-
EMOTIon and COgNitive Function After Atrial Fibrillation Catheter Ablation vs. Medical Therapy(EMOTICON Trial)
NCT04942171 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
NCT00729911 ·Status: COMPLETED ·Phase: PHASE4
-
Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation
NCT02306460 ·Status: TERMINATED
-
Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation
NCT01553045 ·Status: UNKNOWN
-
Catheter Ablation Versus Medical Treatment of AF in Heart Failure
NCT01411371 ·Status: UNKNOWN ·Phase: NA
-
Anticoagulation in AF Ablation and Effects on Neurocognitive Function
NCT02120560 ·Status: WITHDRAWN ·Phase: PHASE4
-
Atherosclerosis in Atrial Fibrillation
NCT01882114 ·Status: UNKNOWN
-
Specific Electrophenotypes in Atrial Fibrillation
NCT05366530 ·Status: TERMINATED
-
EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment
NCT05790707 ·Status: RECRUITING ·Phase: NA
-
Atrial Fibrillation and Congestive Heart Failure Trial
NCT00597077 ·Status: COMPLETED ·Phase: PHASE4
-
Atrial Fibrillation Follow-up Investigation to Recover Memory and learnING Trial
NCT05374642 ·Status: COMPLETED ·Phase: NA
-
New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications
NCT01863979 ·Status: COMPLETED
-
Precision Medicine in Ischemic Stroke and Atrial Fibrillation
NCT04637087 ·Status: COMPLETED ·Phase: NA
-
Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training
NCT02627183 ·Status: COMPLETED
-
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT06200311 ·Status: RECRUITING ·Phase: NA
-
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868 ·Status: NOT_YET_RECRUITING
-
Atrial Fibrillation Health Literacy and Information Technology Trial
NCT04075994 ·Status: COMPLETED ·Phase: NA
-
Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.
NCT06047782 ·Status: RECRUITING ·Phase: NA
-
Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine
NCT01391091 ·Status: COMPLETED ·Phase: PHASE3
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080 ·Status: RECRUITING ·Phase: PHASE3
-
Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF
NCT01183091 ·Status: COMPLETED
-
First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments
NCT02884661 ·Status: COMPLETED
-
Risk Profile for Patients With Atrial Fibrillation
NCT01510210 ·Status: ACTIVE_NOT_RECRUITING